Depression as a modifiable factor to decrease the risk of dementia
- PMID: 28463236
- PMCID: PMC5534958
- DOI: 10.1038/tp.2017.90
Depression as a modifiable factor to decrease the risk of dementia
Abstract
Depression is an accepted risk factor for dementia, but it is unclear if this relationship is causal. This study investigated whether dementia associated with depression decreases with antidepressant use and is independent of the time between exposure to depression and the onset of dementia. We completed a 14-year longitudinal study of 4922 cognitively healthy men aged 71-89 years, and collected information about history of past depression, current depression and severity of depressive symptoms. Other measures included use of antidepressants, age, education, smoking and history of diabetes, hypertension, coronary heart disease, and stroke. The onset of dementia and death during follow-up was ascertained via the Western Australian Data Linkage System. A total of 682 men had past (n=388) or current (n=294) depression. During 8.9 years follow-up, 903 (18.3%) developed dementia and 1884 (38.3%) died free of dementia. The sub-hazard ratios (SHRs) of dementia for men with past and current depression were 1.3 (95% confidence interval (CI)=1.0, 1.6) and 1.5 (95% CI=1.2, 2.0). The use of antidepressants did not decrease this risk. Compared to men with no symptoms, the SHRs of dementia associated with questionable, mild-to-moderate and severe depressive symptoms were 1.2 (95% CI=1.0, 1.4), 1.7 (95% CI=1.4, 2.2) and 2.1 (95% CI=1.4, 3.2), respectively. The association between depression and dementia was only apparent during the initial 5 years of follow-up. Older men with history of depression are at increased risk of developing dementia, but depression is more likely to be a marker of incipient dementia than a truly modifiable risk factor.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Depression, antidepressants and the risk of cardiovascular events and death in older men.Maturitas. 2019 Oct;128:4-9. doi: 10.1016/j.maturitas.2019.06.009. Epub 2019 Jun 28. Maturitas. 2019. PMID: 31561821
-
Risk of dementia in German patients treated with antidepressants in general or psychiatric practices .Int J Clin Pharmacol Ther. 2017 Apr;55(4):322-328. doi: 10.5414/CP202754. Int J Clin Pharmacol Ther. 2017. PMID: 28025968
-
Depression as a risk factor for cognitive impairment in later life: the Health In Men cohort study.Int J Geriatr Psychiatry. 2016 Apr;31(4):412-20. doi: 10.1002/gps.4347. Epub 2015 Aug 17. Int J Geriatr Psychiatry. 2016. PMID: 26280254
-
Depression and the risk for dementia.Curr Opin Psychiatry. 2012 Nov;25(6):457-61. doi: 10.1097/YCO.0b013e328356c368. Curr Opin Psychiatry. 2012. PMID: 22801361 Review.
-
Late-life depression, mild cognitive impairment, and dementia: possible continuum?Am J Geriatr Psychiatry. 2010 Feb;18(2):98-116. doi: 10.1097/JGP.0b013e3181b0fa13. Am J Geriatr Psychiatry. 2010. PMID: 20104067 Review.
Cited by
-
Association of modifiable risk factors with progression to dementia in relation to amyloid and tau pathology.Alzheimers Res Ther. 2024 Oct 26;16(1):238. doi: 10.1186/s13195-024-01602-9. Alzheimers Res Ther. 2024. PMID: 39462394 Free PMC article.
-
Investigating Modifiable Risk Factors Across Dementia Subtypes: Insights from the UK Biobank.Biomedicines. 2024 Aug 31;12(9):1967. doi: 10.3390/biomedicines12091967. Biomedicines. 2024. PMID: 39335481 Free PMC article.
-
Ethno-racial differences in depressive symptom endorsement: Evaluation of brief forms of the Geriatric Depression Scale in older adults.J Affect Disord. 2024 Nov 1;364:274-278. doi: 10.1016/j.jad.2024.08.063. Epub 2024 Aug 13. J Affect Disord. 2024. PMID: 39147158 Free PMC article.
-
Depressive Symptoms Affect Cognitive Functioning from Middle to Late Adulthood: Ethnoracial Minorities Experience Greater Repercussions.J Racial Ethn Health Disparities. 2024 Aug 15. doi: 10.1007/s40615-024-02121-x. Online ahead of print. J Racial Ethn Health Disparities. 2024. PMID: 39145835
-
Apolipoproteine and KLOTHO Gene Variants Do Not Affect the Penetrance of Fragile X-Associated Tremor/Ataxia Syndrome.Int J Mol Sci. 2024 Jul 25;25(15):8103. doi: 10.3390/ijms25158103. Int J Mol Sci. 2024. PMID: 39125677 Free PMC article.
References
-
- Tan CC, Yu JT, Wang HF, Tan MS, Meng XF, Wang C et al. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis 2014; 41: 615–631. - PubMed
-
- Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer’s disease: an analysis of population-based data. Lancet Neurol 2014; 13: 788–794. - PubMed
-
- Lautenschlager NT, Cox KL, Flicker L, Foster JK, van Bockxmeer FM, Xiao J et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA 2008; 300: 1027–1037. - PubMed
-
- Ngandu T, Lehtisalo J, Solomon A, Levalahti E, Ahtiluoto S, Antikainen R et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 2015; 385: 2255–2263. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
